Teza Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,018
| Closed | -$1.26M | – | 777 |
|
|
2024
Q1 | $1.26M | Buy |
3,018
+2,010
| +199% | +$840K | 0.17% | 166 |
|
|
2023
Q4 | $410K | Sell |
1,008
-3,172
| -76% | -$1.29M | 0.07% | 338 |
|
|
2023
Q3 | $1.45M | Buy |
+4,180
| New | +$1.45M | 0.24% | 123 |
|
|
2022
Q1 | – | Sell |
-1,208
| Closed | -$265K | – | 552 |
|
|
2021
Q4 | $265K | Sell |
1,208
-4,201
| -78% | -$922K | 0.07% | 347 |
|
|
2021
Q3 | $981K | Buy |
+5,409
| New | +$981K | 0.47% | 58 |
|
|
2021
Q2 | – | Sell |
-2,280
| Closed | -$490K | – | 706 |
|
|
2021
Q1 | $490K | Buy |
+2,280
| New | +$490K | 0.1% | 281 |
|
|
2018
Q2 | – | Sell |
-4,880
| Closed | -$795K | – | 584 |
|
|
2018
Q1 | $795K | Buy |
4,880
+1,692
| +53% | +$276K | 0.19% | 214 |
|
|
2017
Q4 | $478K | Buy |
+3,188
| New | +$478K | 0.29% | 150 |
|